| GPCRs in cancer: protease-activated receptors, endocytic adaptors and signaling AKS Arakaki, WA Pan, JA Trejo International journal of molecular sciences 19 (7), 1886, 2018 | 81 | 2018 |
| The RNA recognition motif of NIFK is required for rRNA maturation during cell cycle progression WA Pan, HY Tsai, SC Wang, M Hsiao, PY Wu, MD Tsai RNA biology 12 (3), 255-267, 2015 | 61 | 2015 |
| The epidermal growth factor-like domain of CD93 is a potent angiogenic factor YC Kao, SJ Jiang, WA Pan, KC Wang, PK Chen, HJ Wei, WS Chen, ... PloS one 7 (12), e51647, 2012 | 61 | 2012 |
| The nucleolar protein NIFK promotes cancer progression via CK1á/â-catenin in metastasis and Ki-67-dependent cell proliferation TC Lin, CY Su, PY Wu, TC Lai, WA Pan, YH Jan, YC Chang, CT Yeh, ... Elife 5, e11288, 2016 | 57 | 2016 |
| The á-arrestin ARRDC3 suppresses breast carcinoma invasion by regulating G protein–coupled receptor lysosomal sorting and signaling AKS Arakaki, WA Pan, H Lin, JA Trejo Journal of Biological Chemistry 293 (9), 3350-3362, 2018 | 41 | 2018 |
| á-Arrestin ARRDC3 tumor suppressor function is linked to GPCR-induced TAZ activation and breast cancer metastasis AKS Arakaki, WA Pan, H Wedegaertner, I Roca-Mercado, L Chinn, ... Journal of cell science 134 (8), jcs254888, 2021 | 28 | 2021 |
| The á-arrestin ARRDC3 is an emerging multifunctional adaptor protein in cancer H Wedegaertner, WA Pan, CC Gonzalez, DJ Gonzalez, JA Trejo Antioxidants & Redox Signaling 36 (13), 1066-1079, 2022 | 11 | 2022 |
| Cyclin E1 protein overexpression sensitizes ovarian cancer cells to ZN-c3, a novel, selective and oral bioavailable inhibitor of Wee1 J Ma, W Liu, H Chung, H Izadi, P DeJong, O Harismendy, J li, F Doñate, ... AACR 83, 2023 | 2 | 2023 |
| Regulation of GPCR activation of the Hippo pathway in metastatic breast cancer AKS Arakaki, WA Pan, JA Trejo The FASEB Journal 34 (S1), 1-1, 2020 | 2 | 2020 |
| Regulation of alpha‐Arrestin Function in G Protein‐Coupled Receptor Signaling and Trafficking H Wedegaertner, WA Pan, JA Trejo The FASEB Journal 34 (S1), 1-1, 2020 | 1 | 2020 |
| The á‐Arrestin ARRDC3 Suppresses Breast Carcinoma Invasion by Regulating GPCR Lysosomal Sorting and Signaling AK Arakaki, WA Pan, JA Trejo The FASEB Journal 32, 695.13-695.13, 2018 | 1 | 2018 |
| Abstract LB187: Investigating the roles of ROR1/2 in non-small cell lung carcinoma NSCLC and potential therapeutic applications WA Pan, X Guo, C Galang, M Ko, J Kucharski, N Miller, H Moskowitz, ... Cancer Research 84 (7_Supplement), LB187-LB187, 2024 | | 2024 |
| The alpha-arrestin ARRDC3 functions as a metastasis suppressor by regulating GPCR activation of the Hippo pathway. AKS Arakaki, WA Pan, H Wedegaertner, JA Trejo MOLECULAR CANCER RESEARCH 18 (8), 30-31, 2020 | | 2020 |
| Abstract A16: The á-arrestin ARRDC3 functions as a metastasis suppressor by regulating GPCR activation of the Hippo pathway AKS Arakaki, WA Pan, H Wedegaertner, JA Trejo Molecular Cancer Research 18 (8_Supplement), A16-A16, 2020 | | 2020 |
| a‐arrestin ARRDC3 is a Multifunctional Adaptor That Regulates G Protein‐Coupled Receptor Signaling and Breast Cancer Invasion WA Pan, A Arakaki, H Wedegaertner, I Kufareva, JA Trejo The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Tumor Suppressor Alpha‐arrestin ARRDC3 Controls GPCR Signaling and Breast Cancer Invasion WA Pan, A Arakaki, JA Trejo The FASEB Journal 32, 566.14-566.14, 2018 | | 2018 |
| Functions of Ki67 interacting protein NIFK in cell cycle progression, p53 signaling and ribosome biogenesis. WA Pan National Taiwan University, 2015 | | 2015 |
